熱門資訊> 正文

Athira Pharma GAAP每股收益为-1.68美元

2025-11-07 07:02

Athira Pharma(ATHA) 0

Athira Pharma press release (ATHA): Q3 GAAP EPS of -$1.68.
Cash, cash equivalents and investments were $25.2 million as of September 30, 2025, compared to $51.3 million as of December 31, 2024.

More on Athira Pharma

Athira pharma announces 10-for-1 reverse stock split
Seeking Alpha’s Quant Rating on Athira Pharma
Historical earnings data for Athira Pharma
Financial information for Athira Pharma

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。